158 results on '"Tofani L"'
Search Results
2. POS0235 NEW ONSET OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: CLINICAL COURSE AND OUTCOMES FROM A EUSTAR DATABASE ANALYSIS
3. CO144 A Trial-Based Health Utility Analysis in Patients with Acanthamoeba Keratitis
4. SA59 Clinical Evidence on Acanthamoeba Keratitis Treatments: Systematic Literature Review
5. OP0238 IMMUNOSUPPRESSION WITH TARGETED DMARDS REDUCES MORBIDITY AND MORTALITY IN PRE-CAPILLARY PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A EUSTAR ANALYSIS
6. Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?
7. Solid Lipid Nanoparticles for Brain Targeting
8. Is it time to change the diagnostic thresholds for Intrahepatic Cholestasis of pregnancy?
9. Placental expression of Tryptophan degradation enzymes and Angiotensin (1-7) in physiological pregnancies delivered at term
10. Selective pectoralis major muscle denervation in retro-pectoral implant based breast reconstruction reduces capsular contracture rate. Long-term single institution prospective case-control study
11. The positive predictive value of breast lesions of uncertain malignant potential, their correlation with radiologic findings and their follow-up on a large single-institution series
12. AB0747 Oral microbiome in rheumatic diseases.What involvement?
13. POS0388 DEVELOPING A SCREENING TOOL FOR THE DETECTION OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: THE ILD-RISC RISK SCORE
14. IMMUNOSUPPRESSION WITH TARGETED DMARDS REDUCES MORBIDITY AND MORTALITY IN PRE-CAPILLARY PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A EUSTAR ANALYSIS.
15. Risk factors for difficult Laryngeal Mask Airway LMA-Supreme™ (LMAS) placement in adults: A multicentric prospective observational study in an Italian population
16. Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition
17. POS0264 THE EMERGING ROLE OF MAGNETIC RESONANCE IMAGING IN INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: EVIDENCE FOR ULTRA SHORT TE AND COMPRESSED SENSING VIBE ACQUISITIONS AS PROMISING TOOLS FOR THE EVALUATION OF PARENCHYMAL ALTERATIONS
18. POS0842 LUNG ULTRASOUND TO ASSESS THE SEVERITY OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS
19. POS0317 THE PERFORMANCE OF DIFFUSING CAPACITY FOR MONOXIDE CARBON (DLCO) AND FORCED VITAL CAPACITY (FVC) IN PREDICTING THE ONSET OF SYSTEMIC SCLEROSIS (SSc)-INTERSTITIAL LUNG DISEASE (ILD) IN THE EUROPEAN SCLERODERMA TRIALS AND RESEARCH (EUSTAR) DATABASE
20. OP0176 ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC)
21. AB0256 BARICITINIB (BARI) VERSUS BIOLOGICS IMPACT ON STEROID TAPERING IN RHEUMATOID ARTHRITIS (RA)
22. Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?
23. AB0361 EFFICACY AND SAFETY OF BARICITINIB (BARI) IN RHEUMATOID ARTHRITIS(RA): CLINICAL AND ULTRASOUND EVALUATION IN REAL LIFE
24. AB0239 EFFECTS OF DYSMETABOLISMS AND COMORBIDITIES ON THE EFFICACY, SAFETY AND RETENTION RATE OF BIOLOGICAL DMARDS (bDMARD) IN INFLAMMATORY JOINT DISEASES.
25. THU0360 EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS (SSC)
26. AB0281 SAFETY AND RETENTION RATE AFTER SWITCHING FROM ETANERCEPT ORIGINATOR (ETN) TO ETANERCEPT BIOSIMILAR (SB4) IN INFLAMMATORY JOINT DISEASES: DATA FROM REAL LIFE.
27. Caspofungin PK in critically ill patients after the first and fourth doses: suggestions for therapeutic drug monitoring?
28. 74 (PB-074) Poster - The positive predictive value of breast lesions of uncertain malignant potential, their correlation with radiologic findings and their follow-up on a large single-institution series
29. 69 (PB-069) Poster - Selective pectoralis major muscle denervation in retro-pectoral implant based breast reconstruction reduces capsular contracture rate. Long-term single institution prospective case-control study
30. PIN124 - ASSESSING THE VALUE OF NEW ANTIBIOTICS IN ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) WITH A FOCUS ON SURGICAL SITE INFECTION (SSI): A REVIEW OF THE EVIDENCE BASE
31. Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL)
32. THU0425 18f-fluorodeoxyglucose positron emission tomography/computed tomography and lung involvement in systemic sclerosis
33. COMPARISON BETWEEN SECUKINUMAB AND IXEKIZUMAB IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: A SINGLE CENTER EXPERIENCE.
34. Hyperplastic polyps and sessile serrated adenomas: the differential diagnosis dilemma
35. 1673P - Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL)
36. SAT0219 Correlation between Patient-Reported Outcomes and Changes in Digital Ulcer Status in Systemic Sclerosis Patients
37. AB0591 Nailfold Videocapillaroscopy May Not Reflect Change of Digital Ulcers Status in A Short Term Evaluation of Systemic Sclerosis Patients
38. The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course
39. PSN6 COST-EFFECTIVENESS OF BRIVUDINE COMPARED TO ACICLOVIR FOR THE TREATMENT OF HERPES ZOSTER IN GERMANY
40. The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19
41. Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes
42. Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition
43. Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
44. B3 Breast Lesions: Positive Predictive Value and Follow-Up on a Large Single-Institution Series.
45. Doppler-Derived Renal Functional Reserve in the Prediction of Postoperative Acute Kidney Injury in Patients Undergoing Robotic Surgery.
46. Impact of Upadacitinib on Atopic Keratoconjunctivitis Exacerbated by Dupilumab Treatment in Atopic Dermatitis Patients: A Prospective Dermatological and Ophthalmological Clinical Evaluation in Common Clinical Practice.
47. Assessment of skin microvascular response through pregnancy using laser speckle contrast imaging.
48. Dupilumab-associated ocular surface disease or atopic keratoconjunctivitis not improved by dupilumab? Upadacitinib may clarify the dilemma: A case report.
49. Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed Tomography.
50. The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.